Timeline, ridgeline, and split-violin plots can visualise bevacizumab's randomised trial evidence across seven cancer types and support judgements about borrowing information across indications.
Biomarker results from the A V ADO phase 3 trial of first- line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
stat.AP 1years
2025 1verdicts
CONDITIONAL 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab
Timeline, ridgeline, and split-violin plots can visualise bevacizumab's randomised trial evidence across seven cancer types and support judgements about borrowing information across indications.